Skip to content

Oxygen Preconditioning Prevents Contrast-Induced Nephropathy

Oxygen Preconditioning Prevents Contrast-Induced Nephropathy - OPtion CIN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007125
Enrollment
400
Registered
2012-01-24
Start date
2011-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease Congestive Heart Failure Chronic Kidney Disease Peripheral arterial Disease

Interventions

The control patients were applied intravenous hydration with 0.9 % isotonic saline at a rate of 1ml per kilogram per hour (or 0.5ml per kilogram per hour in the case of low ejection fraction lesser th

Sponsors

Yokohama Medical Center (Department of Clinical Research)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who are scheduled for cardiovascular angiography including diagnostic coronary angiography, ventriculography, aortography, and/or coronary or peripheral intervention.

Exclusion criteria

Exclusion criteria: peritoneal dialysis, hemodialysis treatment, cardiogenic shock, congestive heart failure, pregnancy, a history of severe allergies to contrast media, recent major bleeding, having a metformin within 48 hours of the study entry, chronic obstructive pulmonary disease, patient with the oxygen saturation lesser than 90 percent, acute coronary syndrome, severe infection, severe malnutrition, post-operative states, pituitary or adrenal dysfunction, paraquat intoxication

Design outcomes

Primary

MeasureTime frame
Contrast-Induced Nephropathy : defined as an increase in the serum creatinine concentration of 25 percent or 0.5 mg/dl from the baseline at maximum value obtained within 48 hours after the procedure

Secondary

MeasureTime frame
sex, age (more than 70-year-old), hypertension, diabetes mellitus, dyslipidemia, a history of myocardial infarction, BNP(more than 100pg/ml), anemia, use of ACE inhibitors/ARBs, use of diuretics, use of statins, use of contast-medium (more than 150ml), eGFR (less than 60ml/min/1.73m2), PaO2 (more than 100 mmHg) As sub-analysis, among the patients with eGFR under 60ml/min/1.73m2 for CIN high risk group.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026